Want to join the conversation?
$BCR 2Q15 PR: Product Group Net Sales: Vascular net sales increased by 7% YoverY; Urology net sales increased by 1% YoverY; Oncology net sales increased by 5% YoverY; Surgical Specialties net sales increased by 3% YoverY; and Other net sales remained flat YoverY.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?